Prostate-Specific Antigen Density as a Powerful Predictor of Extracapsular Extension and Positive Surgical Margin in Radical Prostatectomy Patients with Prostate-Specific Antigen Levels of Less than 10 ng/ml

Prostate-Specific Antigen Density as a Powerful Predictor of Extracapsular Extension and Positive Surgical Margin in Radical Prostatectomy Patients with Prostate-Specific Antigen Levels of Less than 10 ng/ml

Bibliographic Details
Main Authors:	Chang, Jin-Seok, Choi, Hoon, Chang, Young-Seop, Kim, Jin-Bum, Oh, Mi Mi, Moon, Du Geon, Bae, Jae Hyun, Cheon, Jun
Format:	Online
Language:	English
Published:	The Korean Urological Association 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3246511/

Similar Items

Predictive Factors for Prostate Cancer in Biopsy of Patients with Prostate-Specific Antigen Levels Equal to or Less Than 4 ng/ml
by: Kim, Hyoung Woo, et al.
Published: (2011)

Nomogram for Prediction of Prostate Cancer with Serum Prostate Specific Antigen Less than 10 ng/mL
by: Ahn, Jae Hyun, et al.
Published: (2014)

Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less
by: LIU, Xin, et al.
Published: (2015)

Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/ml
by: Umezawa, Rei, et al.
Published: (2011)

Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml−1
by: Chen, Rui, et al.
Published: (2015)

Prostate-Specific Antigen Mass and Free Prostate-Specific Antigen Mass for Predicting the Prostate Volume of Korean Men With Biopsy-Proven Benign Prostatic Hyperplasia
by: Park, Tae Yong, et al.
Published: (2013)

Evaluation of the Prostate Imaging Reporting and Data System for Magnetic Resonance Imaging Diagnosis of Prostate Cancer in Patients with Prostate-specific Antigen <20 ng/ml
by: Wang, Xuan, et al.
Published: (2016)

Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10–20 ng/mL and normal digital rectal examination
by: Chiu, Peter Ka-Fung, et al.
Published: (2016)

Can a Gleason 6 or Less Microfocus of Prostate Cancer in One Biopsy and Prostate-Specific Antigen Level <10 ng/mL Be Defined as the Archetype of Low-Risk Prostate Disease?
by: Taverna, Gianluigi, et al.
Published: (2012)

Clinical Significance of Free-to-Total Prostate-Specific Antigen (PSA) Ratio in Advanced Prostate Cancer Patients with PSA Less than 0.1 ng/ml after Hormone Treatment
by: Kim, Dae Il, et al.
Published: (2012)

The use of early postoperative prostate-specific antigen to stratify risk in patients with positive surgical margins after radical prostatectomy
by: Vesely, Stepan, et al.
Published: (2014)

Prostate Cancer Can Be Detected Even in Patients with Decreased PSA Less than 2.5 ng/ml after Treatment of Chronic Prostatitis
by: Kim, Young Jung, et al.
Published: (2011)

The Role of Prostate-Specific Antigen in Prostate Cancer Screening
by: Constantin Traian Vasile, et al.
Published: (2014-06-01)

Association of Diet With Prostate Specific Antigen and Prostate Volume
by: Shirazi, Mehdi, et al.
Published: (2014)

Prostate Specific Antigen Based Screening for Prostate Cancer
Published: (2012)

Effect of Transurethral Resection of the Prostate on Storage Symptoms in Patients with Benign Prostatic Hyperplasia of Less than 30 ml
by: Kang, Yu Jin, et al.
Published: (2013)

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer
by: Shahab, Ahmad Anies, et al.
Published: (2013)

Prostate-Specific Antigen fluctuation: what does it mean in diagnosis of prostate cancer?
by: Kim, Jun Seok, et al.
Published: (2015)

Effect of Heamolysis on Prostate-Specific Antigen
by: Sağlam, Hasan S., et al.
Published: (2012)

Prostate-specific antigen in breast disease
by: Niusha
Published: (2008)

Age-specific prostate specific antigen and prostate specific antigen density values in a community-based Indian population
by: Ganpule, Arvind P., et al.
Published: (2007)

Impact of Real-Time Elastography versus Systematic Prostate Biopsy Method on Cancer Detection Rate in Men with a Serum Prostate-Specific Antigen between 2.5 and 10 ng/mL
by: Taverna, Gianluigi, et al.
Published: (2013)

Efficacy of Repeated Transrectal Prostate Biopsy in Men Younger Than 50 Years With an Elevated Prostate-Specific Antigen Concentration (>3.0 ng/mL): Risks and Benefits Based on Biopsy Results and Follow-up Status
by: Park, Ho Gyun, et al.
Published: (2014)

Usefulness of combined androgen blockade therapy with gonadotropin-releasing hormone antagonist for bone metastatic prostate cancer with pretreatment prostate-specific antigen level ≥ 50 ng/mL
by: Takeshi Kashiwabara, et al.
Published: (2018-05-01)

The value of percentage free prostate specific antigen (PSA) in the detection of prostate cancer among patients with intermediate levels of total PSA (4.0–10.0 ng/mL) in Nigeria
by: Ezenwa, E.V., et al.
Published: (2012)

Editorial comment to “The value of percentage free prostate-specific antigen (PSA) in the detection of prostate cancer among patients with intermediate levels of total PSA (4.0–10.0 ng/mL) in Nigeria” and Reply by authors
by: Elabbady, Ahmed, et al.
Published: (2012)

Measurements of tissue polypeptide-specific antigen and prostate-specific antigen in prostate cancer patients under intermittent androgen suppression therapy.
by: Theyer, G., et al.
Published: (1997)

Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0–10.0 ng/ml
by: Chen, Rui, et al.
Published: (2015)

Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2–10 ng/ml
by: Ferro, Matteo, et al.
Published: (2013)

Prostate-Specific Antigen Nadir and Time to Prostate-Specific Antigen Nadir Following Maximal Androgen Blockade Independently Predict Prognosis in Patients with Metastatic Prostate Cancer
by: Hong, Seok Young, et al.
Published: (2012)

Free Prostate-Specific Antigen Provides More Precise Data on Benign Prostate Volume Than Total Prostate-Specific Antigen in Korean Population
by: Choi, Hoon, et al.
Published: (2013)

Prostate-Specific Antigen and Prostate-Specific Antigen Velocity as Threshold Indicators in 11C-Acetate PET/CTAC Scanning for Prostate Cancer Recurrence
by: Dusing, Reginald W., et al.
Published: (2014)

Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan
by: Kitagawa, Yasuhide, et al.
Published: (2014)

Prostate-Specific Membrane Antigen-Based Therapeutics
by: Akhtar, Naveed H., et al.
Published: (2012)

Prostate-specific antigen in serum of women with breast cancer.
by: Giai, M., et al.
Published: (1995)

Prostate-specific antigen testing accuracy in community practice
by: Hoffman, Richard M, et al.
Published: (2002)

Prostate-specific antigen in females: A new tool?
by: Biswas, Tamoghna, et al.
Published: (2011)

Tumor-Associated Antigens for Specific Immunotherapy of Prostate Cancer
by: Kiessling, Andrea, et al.
Published: (2012)

An Analytical Study of Prostate-Specific Antigen Dynamics
by: Esteban, Ernesto P., et al.
Published: (2016)

Prostate-specific antigen-based screening: controversy and guidelines
by: Kim, Eric H, et al.
Published: (2015)